Substernal implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with preexisting Hemodialysis Reliable Outflow graft

Boyle, Thomas A.; Cohen, Joshua; Carrillo, Roger G.

doi:10.1016/j.hrcr.2016.05.006

Cited by 7 publications

(7 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Substernal defibrillation lead positioning has been previously reported using a tunneling tool and peel-away sheath under fluoroscopic guidance similar to the 2-incision SICD implant technique 5, 6. This type of defibrillation lead implantation has also been shown to be feasible in a novel defibrillator system currently undergoing clinical evaluation 7 …”

Section: Discussionmentioning

confidence: 99%

Substernal subcutaneous implantable cardioverter-defibrillator lead placement for the management of inappropriate shocks

Lee

Kiankhooy

et al. 2019

HeartRhythm Case Reports

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Substernal subcutaneous implantable cardioverter-defibrillator lead placement for the management of inappropriate shocks

Lee

Kiankhooy

et al. 2019

HeartRhythm Case Reports

View full text Add to dashboard Cite

“…20 Boyle et al described a patient with a Hemodialysis Reliable Outflow (HeRO) graft (Merit Medical Systems) who was not a candidate for S-ICD or TV-ICD due to the location of the graft and bilateral subclavian occlusion. 21 An S-ICD lead was placed substernally and there were no observed T-wave or artificial potentials; DFT testing was successful at 70 J on two episodes. 21 Bhagwandien et al described a patient with no venous access due to superior vena cava syndrome and a high risk of thrombosis from the femoral approach.…”

Section: Substernal Icd Lead Placementmentioning

confidence: 99%

“…21 An S-ICD lead was placed substernally and there were no observed T-wave or artificial potentials; DFT testing was successful at 70 J on two episodes. 21 Bhagwandien et al described a patient with no venous access due to superior vena cava syndrome and a high risk of thrombosis from the femoral approach. 22 The patient was not a suitable…”

Section: Substernal Icd Lead Placementmentioning

confidence: 99%

The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest

Thompson

Atwater

Boersma

et al. 2022

Cardiovasc electrophysiol

View full text Add to dashboard Cite

Introduction The extravascular implantable cardioverter‐defibrillato (EV ICD) system with substernal lead placement is a novel nontransvenous alternative to current commercially available ICD systems. The EV ICD provides defibrillation and pacing therapies without the potential long‐term complications of endovascular lead placement but requires a new procedure for implantation with a safety profile under evaluation. Methods This paper summarizes the development of the EV ICD, including the preclinical and clinical evaluations that have contributed to the system and procedural refinements to date. Results Extensive preclinical research evaluations and four human clinical studies with >140 combined acute and chronic implants have enabled the development and refinement of the EV ICD system, currently in worldwide pivotal study. Conclusion The EV ICD may represent a clinically valuable solution in protecting patients from sudden cardiac death while avoiding the long‐term consequences of transvenous hardware. The EV ICD offers advantages over transvenous and subcutaneous systems by avoiding placement in the heart and vasculature; relative to subcutaneous systems, EV ICD requires less energy for defibrillation, enabling a smaller device, and provides pacing features such as antitachycardia and asystole pacing in a single system.

show abstract

“…Lead removal should be carried out in cases that require contemporary valve replacement or infective endocarditis repair or for those with retained hardware following failed efforts of its percutaneous removal. Of note, elderly patients with comorbidities face high mortality rates during surgical removal (10,(33)(34)(35).…”

Section: Recommendations For Diagnosis Of Cied Infection and Associatmentioning

confidence: 99%

Clinically Focused Review of Diagnosis and Treatment of Cardiovascular Implantable Electronic Device Infections

Barmpas¹,

Stakos

Pfeiffer³

et al. 2019

Int J Infect

View full text Add to dashboard Cite

Context:The role of cardiac pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices has increasingly prominent in cardiac disease management in the last 50 years. Evidence Acquisition: We reviewed the literature for cardiovascular implantable electronic device (CIED)-related infections, their diagnosis, treatment, complications, and long-term treatment. Results: The most common signs of CIED infection include inflammatory changes in the generator pocket area. Evidence of dehiscence of the infected skin due to percutaneous exposure to the generator or even its leads is commonly reported. Timely diagnosis and subsequent treatment of patients with possible CIED infections are vital, which could otherwise affect prognosis. In the case of CIED-related infections close to the surface of the pocket site without the direct involvement of the device, removal is not deemed necessary. The oral administration of antibiotics with antistaphylococcal activity is suggested for 7 to 10 days. If there is the infection of bloodstream or endocarditis, the extraction of the entire system is considered mandatory along with antimicrobial therapy. Patients who suffer from CIED infections and cannot be subjected to device removal using percutaneous or surgical methods must be given long-term antimicrobial suppressive therapy. Such cases are those who are expected to have a short-term life expectancy or do not accept device removal. Conclusions: CIED infection is life-threatening. Early diagnosis is crucial to the survival of the patients. The use of antibiotics and a conservative approach without the CIED system removal may not be enough to cure this condition.All criteria for inclusion/exclusion of studies were specified before the literature search. Eligible studies for the systematic review included clinical trials, observational cohort studies, case-control studies, case series, or case re-

show abstract

Substernal implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with preexisting Hemodialysis Reliable Outflow graft

Cited by 7 publications

References 11 publications

Substernal subcutaneous implantable cardioverter-defibrillator lead placement for the management of inappropriate shocks

Substernal subcutaneous implantable cardioverter-defibrillator lead placement for the management of inappropriate shocks

The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest

Clinically Focused Review of Diagnosis and Treatment of Cardiovascular Implantable Electronic Device Infections

Contact Info

Product

Resources

About